Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial.

Maria ChaparroMaría G DondayManuel Barreiro-de AcostaEugeni DomènechMaría EsteveValle García-SánchezPilar NosJulián PanésConcepción MartínezJavier P Gisbert

Published in: Therapeutic advances in gastroenterology (2019)

EudraCT 2015-001410-10.

Keyphrases

study protocol
end stage renal disease
randomized controlled trial
clinical trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
cross sectional
open label
ulcerative colitis